View Older Stories
-
Top 10 News Items 2/14-2/18: NYSE Euronext/Deutsche Boerse Announces Definitive Agreement, Sanofi, Genzyme Finally Approve Deal, Stocks Continue Higher, Up 28% Since Sept.
-
Pre-Open Movers 2/16: (FDO) (VCLK) (DELL) Higher; (TNGN) (DSCO) (OMX) Lower
-
Paulson's Paulson & Co. Reduces Citi (C) Exposure; Keeps Gold Level; Likes Tech (STX)(RIG)ABX)(JPM)
-
Citi Resumes Coverage on Genzyme (GENZ) at Hold
-
Cohen's SAC Capital 13F Highlights: New Positions in McMoRan, Regis, Raised Stakes in Genzyme, Hertz, Sprint, Lowered Stakes in Apple, Exxon Mobil
-
Raised Bid for Genzyme (GENZ) Could Be Coming as Sanofi (SNY) Scrounging for More Financing
-
Wall Street Hubbub 8/31: Saks In the Crosshairs, JPMorgan To Close Prop-Trading, Dean Foods Takeover Chatter, Dell Up To Bat on 3PAR
-
Citigroup Sees Sanofi (SNY) Paying $74-$77 for Genzyme (GENZ)
-
Active equity option families in first 30-minutes of trading: AAPL C HPQ GENZ PAR
-
Citigroup Downgrades Genzyme (GENZ) to Hold
-
Citi Maintains a 'Buy' on Genzyme (GENZ); Manufacturing Saga Continues- Cerezyme On Track, But Fabrazyme Lost
-
Notable Analyst Rating Changes 06/01: LVS, GENZ, V, CPT Upgraded; CNK, BEAT, GLW, AEO Downgraded
-
Citi Announces Highlights from Recent Healthcare Conference
-
Acorda (ACOR) Ticks Higher On New "Hold" Rating Which Discounts M&A Talk
-
Merriman Curhan Ford Maintains a 'Buy' on Cyclacel Pharmaceuticals (CYCC); Raises PT Range
-
Citigroup Upgrades Genzyme (GENZ) to Buy
-
Notable Analyst Rating Changes 9/24: MTH, NSM, WFC, AIMC, CPN, SHFL Higher; LLL, AZN, VIP, ANN, KGC, UFS Downgraded
-
Notable Analyst Rating Changes 9/18: ETFC, SNDK, TOL, SBUX, PG, AMED Upgraded; SCHW, GENZ, MDC, IMAX, MOT Downgraded
-
Barclays Gets Bullish On US Biotechnology Sector (BBH)
-
Piper Jaffray Initiates Coverage on Genzyme (GENZ) with a Buy; Attractive Entry Point
-
Deutsche Bank Upgrades Genzyme (GENZ) to Buy; Myozyme Delays Create Buying Opportunity
-
David Moenning's Daily State of the Markets: 3/6
-
Morning Movers 3/6: Wells Fargo (WFC) Up On Dividend Cut, FairPoint (FRP) Slammed On Results
-
David Moenning's Daily State of the Markets: 3/3
-
Notable Analyst Rating Changes 3/3: DWA, BBD, ARO Upgraded; UBS, CS, DHI, CTX, GENZ Downgraded
-
Citi Downgrades Genzyme (GENZ) to Hold, Citing Lack of Visibility
-
Citi Downgrades BioMarin Pharmaceutical (BMRN) to Hold, Citing Disappointing Guidance
-
David Moenning's Daily State of the Markets: 10/22
-
Notable Analyst Rating Changes 9/8: GS, AMD, RIMM, NLY Upgraded; AZO, NOK, RFMD, GSK Downgraded
-
Notable Analyst Rating Changes 9/5: UL, MON, NAV, HOS Upgraded; ANF, TJX, AMD, NBR Downgraded
-
David Moenning's Daily State of the Markets: 7/23
-
David Moenning's Daily State of the Markets: 7/14
-
Notable Analyst Rating Changes 7/14: NOV, AA, GENZ, M Upgraded; UAUA, ZION, HOT, DB Downgraded
-
Pre-Open Movers 7/14: Fannie (FNM), Freddie (FRE) Up On U.S. Back-Stop Plan; Republic Services (RSG) Up on Waste Management Offer
-
Citi Upgrades Genzyme (GENZ) to Buy
-
Notable Analyst Rating Changes 7/1: SIRI, AXP, NVDA, CTAS Upgraded; FO, ALTR, RBN Downgraded

